Expanded Indications in the MED-EL Pediatric Cochlear Implant Population

  • End date
    Jul 9, 2022
  • participants needed
  • sponsor
    Med-El Corporation
Updated on 9 March 2021
cochlear implant
profound sensorineural hearing loss


The purpose of this investigation is to demonstrate the safety and effectiveness of MED-EL cochlear implants in children 7 months to 5 years, 11 months of age who fall outside the current FDA-approved candidacy criteria and, yet, continue to demonstrate insufficient functional access to sound with appropriately fit hearing aids and aural habilitation.

Condition Sensorineural hearing loss
Treatment MED-EL SYNCHRONY PIN Cochlear Implant
Clinical Study IdentifierNCT03900897
SponsorMed-El Corporation
Last Modified on9 March 2021


Yes No Not Sure

Inclusion Criteria

Children 7 months to 5 years 11 months of age at the time of implantation
Bilateral, severe to profound sensorineural hearing loss (SNHL) in the high frequencies and
For subjects implanted under 12 months of age: bilateral, severe to profound SNHL in the low frequencies
For subjects implanted at 12 months to 5 years 11 months of age: bilateral, mild to profound sensorineural hearing loss in the low frequencies
Insufficient functional access to sound with appropriately fit amplification and aural habilitation
Objective measures consistent with repeatable unaided audiometric thresholds for subjects under 12 months of age
Radiologic evidence of potential for full insertion with one of the included electrode arrays
Ability to undergo general anesthesia
At least one parent/guardian who is fluent in one of the available languages of the LEAQ
Parental commitment to study parameters

Exclusion Criteria

Magnetic Resonance Imaging (MRI) evidence of cochlear nerve deficiency
Active middle ear infection
Permanent conductive hearing loss
Treatable mixed hearing loss
Current or history of meningitis
Common cavity
Skin or scalp condition precluding use of external audio processor
Suspected cognitive impairment, organic brain dysfunction, or syndromic etiology that may affect performance
ASA (American Society of Anesthesiologists) Class 3 or higher in subjects under 12 months of age
History of prior use of a hearing implant
Unrealistic parental/patient expectations
Child is not able to complete speech perception testing in English
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note